Enko Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 16

Enko General Information

Description

Developer of sustainable small molecule technologies designed for farmers to protect their crops from pests and disease. The company uses Deoxyribonucleic Acid (DNA)-encoded libraries, artificial intelligence, structure-based design, and machine learning to find and select the right treatments for the right targets faster and more effectively than traditional research and development methods, enabling farmers with new tools to grow and protect their crops successfully and sustainably.

Contact Information

Website
www.enko.ag
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 62 Maritime Drive
  • Mystic, CT 06355
  • United States
+1 (857)
Primary Industry
Agricultural Chemicals
Other Industries
Other Agriculture
Corporate Office
  • 62 Maritime Drive
  • Mystic, CT 06355
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enko Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Later Stage VC (Series C) 30-Nov-2022 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Jun-2021 Completed Generating Revenue
2. Early Stage VC (Series A1) 19-Apr-2019 $15M $21M Completed Generating Revenue
1. Early Stage VC (Series A) 30-May-2017 $6M $6M Completed Startup
To view Enko’s complete valuation and funding history, request access »

Enko Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A1 9,999,998 $0.000100 $1.5 $1.5 1x $1.5 14.73%
Series A 6,000,000 $0.000100 $1 $1 1x $1 8.84%
To view Enko’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Enko Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of sustainable small molecule technologies designed for farmers to protect their crops from pests and disease.
Agricultural Chemicals
Mystic, CT
50 As of 2024

Santa Monica, CA
 

Whippany, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enko Competitors (24)

One of Enko’s 24 competitors is Provivi, a Private Equity-Backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Provivi Private Equity-Backed Santa Monica, CA
Bayer CropScience United States Formerly VC-backed Whippany, NJ
Crop Enhancement Venture Capital-Backed San Jose, CA
Syngenta Formerly Accelerator/Incubator backed Basel, Switzerland
Vive Crop Protection Venture Capital-Backed Mississauga, Canada
You’re viewing 5 of 24 competitors. Get the full list »

Enko Patents

Enko Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026097031-A1 Process for manufacturing 6-perfluorophenyl benzoxazinones Pending 04-Nov-2024
WO-2024238566-A2 Process for manufacturing 6-perfluorophenyl benzoxazinones Inactive 15-May-2023
WO-2024238566-A3 Process for manufacturing 6-perfluorophenyl benzoxazinones Inactive 15-May-2023
US-20260256143-A1 Herbicidal composition and method for controlling weeds Pending 14-Mar-2023
WO-2024192154-A1 Herbicidal composition and method for controlling weeds Inactive 14-Mar-2023 A01N43/84
To view Enko’s complete patent history, request access »

Enko Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enko Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Akroyd LLC Corporation Minority
DYDX Venture Capital Minority
Endeavor8 Venture Capital Minority
Angel (individual) Minority
Alumni Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Enko FAQs

  • When was Enko founded?

    Enko was founded in 2017.

  • Where is Enko headquartered?

    Enko is headquartered in Mystic, CT.

  • What is the size of Enko?

    Enko has 50 total employees.

  • What industry is Enko in?

    Enko’s primary industry is Agricultural Chemicals.

  • Is Enko a private or public company?

    Enko is a Private company.

  • What is Enko’s current revenue?

    The current revenue for Enko is .

  • How much funding has Enko raised over time?

    Enko has raised $151M.

  • Who are Enko’s investors?

    Akroyd LLC, DYDX, Endeavor8, , and Alumni Ventures are 5 of 16 investors who have invested in Enko.

  • Who are Enko’s competitors?

    Provivi, Bayer CropScience United States, Crop Enhancement, Syngenta, and Vive Crop Protection are some of the 24 competitors of Enko.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process